Viridian Therapeutics Shares Jump as REVEAL-1 Phase 3 Hits Primary Endpoint in Thyroid Eye Disease

Viridian Therapeutics (NASDAQ:VRDN) reported top-line results from its REVEAL-1 Phase III clinical trial evaluating ...
Verywell Health on MSN

IV vs. subcutaneous cancer therapies: What’s the difference?

Medically reviewed by Marla Anderson, MD Key Takeaways IV therapy delivers cancer medicine directly into a vein and often ...
Worcester Telegram

IV drip services are expanding in Central Mass. Do they work?

Prices for IV services at Vita range from $90 to $270, depending on the drip, and Giannopoulos might be one of her own best ...
Dallas ObserverOpinion

Dallas County Can Lead the Way Away From the Hidden Cruelty of Lethal Injection

Dallas County has played an outsized role in this grim history. Sixty inmates subjected to lethal injection in Texas received ...

Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...
Courthouse News Service

11th Circuit confirms lethal injection execution for Georgia inmate wanting firing squad

In his complaint, Michael Wade Nance said his veins were so severely compromised that they were likely to blow and cause him ...
Business Standard

Glenmark Pharma gains as US arm to launch Potassium Phosphates Injection

Glenmark Pharmaceuticals rose 1.04% to Rs 2,192.50 after its US arm, Glenmark Pharmaceuticals Inc., will launch Potassium Phosphates Injection USP in multiple strengths in the US market. The injection ...